ENTITY
Grifols SA

Grifols SA (GRF SM)

83
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Grifols SA
•01 Jul 2024 00:17

Another Debt Downgrade

​Moody's downgrades Grifols' rating due to high leverage and opaque governance. For risk-tolerant investors, the current low share price could...

Share
bullish•Grifols SA
•22 Jun 2024 05:04•Syndicated

Grifols S A (GRF/P SM) - Friday, Mar 22, 2024

Gotham City Research's short report on Grifols is seen as misguided, creating a buying opportunity for investors. Grifols is still viewed as a...

Share
bullish•Grifols SA
•16 May 2024 07:14

Liquid Universe of European Ordinary and Preferred Shares: May‘24 Report

Since mid-April, spreads have generally tightened across our European liquid universe of ordinary and preferred shares (12 have tightened, 7...

Share
bearish•Grifols SA
•18 Apr 2024 00:04

Liquid Universe of European Ordinary and Preferred Shares: April‘24 Report

Since mid-March, spreads have generally widened across our European liquid universe of ordinary and preferred shares (5 have tightened, 12 widened,...

Share
bullish•Grifols SA
•16 Jan 2024 18:56

Liquid Universe of European Ordinary and Preferred Shares: January‘24 Report

Since mid-December, spreads have generally tightened across our European liquid universe of ordinary and preferred shares. The spread of Grifols...

Share
x